Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/002755 stock hub

SHE/002755 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002755is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002755

In the news

Latest news · SHE/002755

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E63.4

P25 23.5P50 41.3P75 83.2

ROE8.1

P25 -0.9P50 4.1P75 8.8

ROIC24.9

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002755 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

CNY

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	799
Employees Change	-189%
Employees Change Percent	-19.13
Enterprise value	CNY 14.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001X92
Last refreshed	2026-05-10
Market cap	CNY 16.5B
Price	CNY 17.73
Price currency	CNY
Rev Per Employee	2,193,055.69x
Sector	Healthcare
Sic	2834
Symbol	she/002755
Website	https://www.ask-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.62%
EV Earnings	52.79x
EV/EBIT	55.39x
EV/EBITDA	35.79x
EV/FCF	39.51x
EV/Sales	8.02x
FCF yield	2.16%
P/B ratio	4.87x
P/E ratio	63.44x
P/S ratio	9.39x
PE Ratio3 Y	73.95x
PE Ratio5 Y	59.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.49%
EBITDA Margin	22.26%
FCF margin	20.31%
Gross margin	80.54%
Gross Profit	CNY 1.4B
Gross Profit Growth	-5.73%
Gross Profit Growth Q	-3.43%
Gross Profit Growth3 Y	-0.35%
Gross Profit Growth5 Y	-17.52%
Net Income	CNY 266.3M
Net Income Growth	45.16%
Net Income Growth Q	54.34%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth5 Y	-19.61%
Pretax Margin	17.93%
Profit Margin	15.2%
Profit Per Employee	CNY 333,340
Profitable Years	2
ROA	3.62
Roa5y	-0.24
ROCE	7.35
ROE	8.07
Roe5y	1.52
ROIC	24.87
Roic5y	0.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.25%
Cagr3y	17.04%
Cagr5y	6.02%
Div CAGR3	6.27%
Div CAGR5	-11.42%
EPS Growth	38.32
EPS Growth Q	50
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth5 Y	-20.22
FCF Growth	81.17%
FCF Growth Q	-89.12%
FCF Growth5 Y	0.23%
OCF Growth	62.57%
OCF Growth Q	0.54%
OCF Growth5 Y	7.18%
Revenue Growth	-4.65x
Revenue Growth Q	-5.27x
Revenue Growth Years	2x
Revenue Growth3 Y	1.5x
Revenue Growth5 Y	-15.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.4
Assets	CNY 4.5B
Cash	CNY 2.5B
Current Assets	CNY 2.9B
Current Liabilities	CNY 1.1B
Debt	CNY 6.3M
Debt EBITDA	CNY 0.02
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 3.4B
Interest Coverage	144.1
Liabilities	CNY 1.1B
Long Term Assets	CNY 1.6B
Long Term Liabilities	CNY 74.4M
Net Cash	CNY 2.5B
Net Cash By Market Cap	CNY 15.04
Net Cash Growth	11.1%
Net Debt EBITDA	CNY -6.34
Net Debt Equity	CNY -0.73
Net Debt FCF	CNY -6.95
Tangible Book Value	CNY 2.7B
Tangible Book Value Per Share	CNY 2.95
WACC	5.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.73
Inventory Turnover	2.23
Net Working Capital	CNY -625.6M
Quick ratio	2.51
Working Capital	CNY 1.9B
Working Capital Turnover	CNY 0.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.95%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 0.12
Dividend Years	1
Dividend Yield	0.68%
Last Dividend	CNY 0.12
Payout Ratio	41.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.25%
200-day SMA	19.06
3Y total return	60.33%
50-day SMA	15.43
50-day SMA vs 200-day SMA	50under200
5Y total return	33.93%
All Time High	29
All Time High Change	-38.86%
All Time High Date	2025-08-01
All Time Low	6.5
All Time Low Change	172.77%
All Time Low Date	2024-02-08
ATR	0.75
Beta	0.21
Beta1y	0.38
Beta2y	0.31
Ch YTD	8.57
High	18.1
High52	29
High52 Date	2025-08-01
High52ch	-38.86%
Low	16.67
Low52	13.38
Low52 Date	2026-03-23
Low52ch	32.51%
Ma50ch	14.88%
Price vs 200-day SMA	-6.97%
RSI	67.27
RSI Monthly	54.45
RSI Weekly	54.02
Sharpe ratio	-0x
Sortino ratio	0.13
Total Return	-4.27%
Tr YTD	8.57
Tr1m	11.51%
Tr1w	6.04%
Tr3m	9.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 253.9M
Operating Income Growth	111.4
Operating Income Growth Q	139.7
Operating Income Growth5 Y	-20.54
Operating margin	14.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	243,132,832%
Net Borrowing	-50,953,329
Shares Insiders	1.14%
Shares Institutions	11.46%
Shares Out	928,160,351
Shares Qo Q	-5.6%
Shares Yo Y	4.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 355.9M
Average Volume	19,868,652x
Bv Per Share	3.56
CAPEX	CNY -296.8M
Ch1m	11.51
Ch1w	6.04
Ch1y	-0.39
Ch3m	9.58
Ch3y	59.3
Ch5y	29.7
Ch6m	-4.32
Change	5.91%
Change From Open	5.6
Close	16.74
Days Gap	0.3
Depreciation Amortization	136,183,542
Dollar Volume	570,620,422.9
Earnings Date	2026-04-29
EBIT	CNY 253.9M
EBITDA	CNY 390M
EPS	CNY 0.28
F Score	4
FCF	CNY 355.9M
FCF EV Yield	2.53x
FCF Per Share	CNY 0.38
Financing CF	-162,474,198
Fiscal Year End	December
Founded	2,003
Graham Number	4.72899
Graham Upside	-73.33
Income Tax	CNY 47.6M
Investing CF	-330,484,071
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	CNY 1.4
Lynch Upside	-92.12
Ma150	17.17
Ma150ch	3.29%
Ma20	16.09
Ma20ch	10.17%
Net CF	158,040,840
Next Earnings Date	2026-08-28
Open	16.79
P FCF Ratio	46.24
P OCF Ratio	25.21
Payment Date	2025-06-16
Position In Range	74.13
Ppne	407,456,550
Price Date	2026-05-08
Price EBITDA	CNY 42.19
Ptbv Ratio	6.01
Relative Volume	1.7x
Revenue	1,752,251,500x
Tax By Revenue	2.71x
Tax Rate	15.14%
Tr6m	-4.32%
Volume	32,183,893
Z Score	10.97

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002755 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.12 annual per share

Payout ratio

+41.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-11.4%

1 consecutive years of growth

Total shareholder yield

-4.3%

Dividend yield + buyback yield combined

Performance

SHE/002755 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002755?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.5%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.9%

Negative means the company is buying back shares.

Technical

SHE/002755 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.3

Neutral momentum band

Price vs 200-day MA

-7.0%

50/200-day relationship not available

Beta (5Y)

0.21

Less volatile than the market

Sharpe ratio

-0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002755

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002755 stock rating?

she/002755 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002755 analysis?

The full report lives at /stocks/she/002755/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002755?

The latest report frames she/002755 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002755 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.